HK1160218A1 - Asc as a marker for lung cancer asc - Google Patents

Asc as a marker for lung cancer asc

Info

Publication number
HK1160218A1
HK1160218A1 HK12100306.5A HK12100306A HK1160218A1 HK 1160218 A1 HK1160218 A1 HK 1160218A1 HK 12100306 A HK12100306 A HK 12100306A HK 1160218 A1 HK1160218 A1 HK 1160218A1
Authority
HK
Hong Kong
Prior art keywords
asc
marker
lung cancer
lung
cancer
Prior art date
Application number
HK12100306.5A
Other languages
English (en)
Chinese (zh)
Inventor
Herbert Andres
Marie-Luise Hagmann
Johann Karl
Markus Roessler
Michael Tacke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1160218A1 publication Critical patent/HK1160218A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK12100306.5A 2008-07-03 2012-01-11 Asc as a marker for lung cancer asc HK1160218A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08012070 2008-07-03
PCT/EP2009/004765 WO2010000467A1 (en) 2008-07-03 2009-07-01 Asc as a marker for lung cancer

Publications (1)

Publication Number Publication Date
HK1160218A1 true HK1160218A1 (en) 2012-08-10

Family

ID=39865465

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12100306.5A HK1160218A1 (en) 2008-07-03 2012-01-11 Asc as a marker for lung cancer asc

Country Status (8)

Country Link
US (1) US10175241B2 (de)
EP (1) EP2297581B1 (de)
JP (1) JP5298188B2 (de)
CN (1) CN102138074B (de)
CA (1) CA2728153C (de)
ES (1) ES2408964T3 (de)
HK (1) HK1160218A1 (de)
WO (1) WO2010000467A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012101283A1 (en) * 2011-01-28 2012-08-02 Biosystems International Sas Combinatorial biomarkers for clinical applications in lung cancer patient management
US9851357B2 (en) * 2013-07-15 2017-12-26 Inserm (Institute National De La Sante Et De La Recherche Medicale Method for the prognosis of survival time of a patient suffering from a solid cancer
CN106868104A (zh) * 2015-12-10 2017-06-20 益善生物技术股份有限公司 肺癌循环肿瘤细胞分型鉴定试剂盒
CN105891482B (zh) * 2016-03-29 2017-12-19 复旦大学附属中山医院 一种基于生物标志物谱针对中国农村人口肺结节人群的肺癌风险预测模型
CN105717147B (zh) * 2016-03-29 2018-11-23 复旦大学附属中山医院 一种基于ct影像及生物标志物谱针对中国城市人口肺结节人群的肺癌风险预测试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2386476A1 (en) * 1999-10-18 2001-04-26 Emory University Tms1 compositions and methods of use
WO2005040806A2 (en) 2003-10-15 2005-05-06 Roche Diagnostics Gmbh Use of protein asc as a marker for breast cancer
ATE496142T1 (de) * 2004-03-23 2011-02-15 Oncotherapy Science Inc Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
JP2006061002A (ja) * 2004-07-27 2006-03-09 Sc Bioscience Corp 新規なａｓｃ様タンパク質およびそれをコードする新規遺伝子
DE602005013430D1 (de) 2004-12-23 2009-04-30 Roche Diagnostics Gmbh Verwendung von asc als marker für kolorektalkarzinome
CN101088012A (zh) 2004-12-23 2007-12-12 霍夫曼-拉罗奇有限公司 Asc作为结肠直肠癌的标记的用途
WO2008014951A1 (en) * 2006-08-01 2008-02-07 Roche Diagnostics Gmbh Use of nnmt as a marker for lung cancer
EP2508623B1 (de) * 2006-11-20 2015-08-12 The Johns Hopkins University DNA-Methylierungsmarker und Verwendungsverfahren
MX2010004671A (es) * 2007-12-10 2010-05-27 Hoffmann La Roche Seprasa como marcador para cancer.

Also Published As

Publication number Publication date
EP2297581B1 (de) 2013-04-03
US10175241B2 (en) 2019-01-08
ES2408964T3 (es) 2013-06-24
JP2011521240A (ja) 2011-07-21
CA2728153C (en) 2015-01-27
CN102138074B (zh) 2014-08-13
WO2010000467A8 (en) 2010-03-11
EP2297581A1 (de) 2011-03-23
JP5298188B2 (ja) 2013-09-25
CN102138074A (zh) 2011-07-27
WO2010000467A1 (en) 2010-01-07
US20110171676A1 (en) 2011-07-14
CA2728153A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
HK1162669A1 (en) Pacap as a marker for cancer pacap
GB2459228B (en) Exosome-associated microrna as a diagnostic marker
EP2617730A4 (de) Lungenkrebs-identifikationsmarker
EP2253714A4 (de) Verfahren zur erkennung von lungenkrebs mit hilfe lungenkrebsspezifischer methylierungsmarkergene
EP2258395A4 (de) Therapeutischer wirkstoff zur behandlung von lungenfibrose
HK1151734A1 (en) Therapeutic for hepatic cancer
GB0717101D0 (en) Tumour marker
PL2176664T3 (pl) Ccr4 jako marker nowotworowy
PL2460403T3 (pl) Mysi model stłuszczeniowego zapalenia wątroby-raka wątroby
HK1166130A1 (en) Use of s-erbb-3 as a marker for cancer s-erbb-3
GB0724412D0 (en) Marker
EP2346531A4 (de) Tumorimpfstoff
ZA201200888B (en) New tumor marker
HK1160218A1 (en) Asc as a marker for lung cancer asc
AU320441S (en) Marker
GB2477687B (en) X-ray marker
HK1165204A1 (en) Cybp as a marker of lung cancer cybp
EP2250290A4 (de) Pttg1 als biomarker zur krebsbehandlung
GB0809689D0 (en) Markers for prostate cancee
GB0809327D0 (en) Fifth wheel setting guide
EP2187216A4 (de) Neuer leberkrebsmarker
EP2319873A4 (de) Dextran zur behandlung von lungenkrebs
GB0703654D0 (en) Sterimatic dose marker
GB0800637D0 (en) Evidence marker
GB0807961D0 (en) Renal cancer marker

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190627